Tag:
Mexico
Latest Headlines
Latest Headlines
Another day, another deal for Valeant's Pearson
Valeant Pharmaceuticals ( $VRX ) made the M&A news again today: This time, the Canadian drugmaker scored some assets from Atlantis Pharma, a Mexican branded-generics company, for $71 million.
FDA warns Cadila, slaps ban on Dr. Reddy's
Just as Indian pharma-watchers were beginning to hope for a clean slate at the FDA, the agency has cracked down on two drugmakers. A Dr. Reddy's plant in Mexico is now under an import ban until
Dr. Reddy's tarnished by FDA warning, fire probe
Dr. Reddy's is facing regulatory troubles on two continents. The branded generics maker has received an FDA warning letter concerning an intermediates and API manufacturing plant in Mexico. And it's
FDA warns Dr Reddy's on Mexico plant's shortfalls
Indian generics maker Dr Reddy's Laboratories has run afoul of FDA's manufacturing standards at a Mexican facility that's key to its operations in that country--and to its supplies for the U.S.
Mexico mulls more pharma antitrust probes
Mexican regulators could be on the verge of a pharma push. On the heels of fines levied on drugmakers accused of colluding to raise prices, the country's top antitrust official said that new probes
Novavax shares surge on promising H1N1 trial data
Shares of Novavax (NVAX) spiked as high as 16 percent on Wednesday after the vaccine developer reported some encouraging results from its clinical trial in Mexico for its experimental H1N1 vaccine.
Rotavirus vax campaign would save millions of lives
Each year, more than half a million children around the world die from rotavirus infection--more than half of them in sub-Saharan Africa. But now two new studies conclude that a widespread
Takeda aims abroad with new sales units
Takeda Pharmaceutical ( TKPH ) is taking on the world. It's launching four new overseas subsidiaries to market its products, aiming to expand its territory substantially. The four units will be based
Mexico orders shutdown to slow swine flu
Anxious to slow the spread of a swine flu epidemic that has now claimed up to 176 victims, the Mexican government is ordering most people to stay home for five days. Companies and government offices
Sanofi in yet another emerging-market buyout
Sanofi-Aventis is on a dealmaking roll. The company is set to acquire Brazilian generics maker Medley, according to a local paper, for $670 million. The French pharma just snapped up Laboratorios
